The association of body composition on chemotherapy toxicities in non‐metastatic colorectal cancer patients: a systematic review
ANZ Journal of Surgery · 2024
DOI: 10.1111/ans.18812 ↗Kurz gefasst
Systematische Übersicht in der Zeitschrift ANZ Journal of Surgery, 2024. Verfasst von Cheuk Shan Choi und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Surgery, Western Precinct, University of Melbourne, Melbourne, Victoria, Australia. Hauptthemen laut MEDLINE: Colorectal Neoplasms, Body Composition. Die Arbeit wurde bisher 23-mal zitiert (Crossref) und nennt 27 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).
Themen: Onkologische Pflege
Abstract (Originalsprache)
Background
In recent years, certain body composition measures, assessed by computed tomography (CT), have been found to be associated with chemotherapy toxicities. This review aims to explore available data on the relationship between skeletal muscle and adiposity, including visceral adipose tissue (VAT), subcutaneous adipose tissue (SAT), intramuscular and intermuscular adipose tissue and their association with chemotherapy toxicity in non‐metastatic colorectal cancer (CRC) patients.
Methods
A systematic literature search following PRISMA guidelines was conducted in Medline, Embase, Cochrane and Web of Science, for papers published between 2011 and 2023. The search strategy combined keywords and MESH terms relevant to ‘body composition’, ‘chemotherapy toxicities’, and ‘non‐metastatic colorectal cancer’.
Results
Out of 3868 studies identified, six retrospective studies fulfilled the inclusion criteria with 1024 eligible patients. Low skeletal muscle mass was strongly associated with increased incidence of both chemotherapy toxicities and dose‐limiting toxicity (DLT). The association of VAT, intramuscular and intermuscular adiposity was heterogeneous and inconclusive. There was no association between SAT and chemotherapy intolerance. No universal definitions or cut‐offs for sarcopenia and obesity were noted. All studies utilized 2‐dimensional (2D) CT slices for CT body composition assessment with varied selection on the vertebral landmark and inconsistent reporting of tissue‐defining Hounsfield unit (HU) measurements.
Conclusion
Low skeletal muscle is associated with chemotherapy toxicities in non‐metastatic CRC. However, quality evidence on the role of adiposity is limited and heterogeneous. More studies are needed to confirm these associations with an emphasis on a more coherent body composition definition and an approach to its assessment, especially regarding sarcopenia.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Surgery, Western Precinct, University of Melbourne, Melbourne, Victoria, Australia.
- Western Health Library Service, Western Health, Melbourne, Victoria, Australia.
- Department of Medical Oncology, Western Health, Melbourne, Victoria, Australia.
- Department of Colorectal Surgery, Western Health, Melbourne, Victoria, Australia.
ORCID-Profile: Cheuk Shan Choi
Zitieren
APA
Choi, C. S., Kin, K., Cao, K., Hutcheon, E., Lee, M., Chan, S. T. F., Arafat, Y., Baird, P. N., & Yeung, J. M. C. (2024). The association of body composition on chemotherapy toxicities in non‐metastatic colorectal cancer patients: a systematic review. ANZ Journal of Surgery. https://doi.org/10.1111/ans.18812
Vancouver
Choi CS, Kin K, Cao K, Hutcheon E, Lee M, Chan STF, et al. The association of body composition on chemotherapy toxicities in non‐metastatic colorectal cancer patients: a systematic review. ANZ Journal of Surgery. 2024. doi:10.1111/ans.18812
BibTeX
@article{Choi2024,
author = {Choi, Cheuk Shan and Kin, Kamol and Cao, Ke and Hutcheon, Evelyn and Lee, Margaret and Chan, Steven T F and Arafat, Yasser and Baird, Paul N and Yeung, Justin M C},
title = {The association of body composition on chemotherapy toxicities in non‐metastatic colorectal cancer patients: a systematic review},
journal = {ANZ Journal of Surgery},
year = {2024},
doi = {10.1111/ans.18812}
}
EUVIMED